Listed below are 5 shares added to the Zacks Rank #5 (Sturdy Promote) Record at this time:
Listed below are 5 shares added to the Zacks Rank #5 (Sturdy Promote) Record at this time:
GreenTree Hospitality Group Ltd. GHG develops leased-and-operated and franchised-and-managed inns. The Zacks Consensus Estimate for its present yr earnings has been revised 6.5% downward over the past 30 days.
Neurocrine Biosciences, Inc. NBIX is a commercial-stage biopharmaceutical firm that discovers and develops therapeutics for the remedy of neurological, endocrine, and psychiatric issues. The Zacks Consensus Estimate for its present yr earnings has been revised 40.5% downward over the past 30 days.
Stable Biosciences Inc. SLDB is a life science firm, engages in creating therapies for duchenne muscular dystrophy. The Zacks Consensus Estimate for its present yr earnings has been revised 3.9% downward over the past 30 days.
Fennec Prescribed drugs Inc. FENC is a biopharmaceutical firm that develops product candidates to be used within the remedy of most cancers. The Zacks Consensus Estimate for its present yr earnings has been revised 5% downward over the past 30 days.
NewAge, Inc. NBEV develops, markets, sells, and distributes wholesome liquid dietary dietary supplements and ready-to-drink drinks. The Zacks Consensus Estimate for its present yr earnings has been revised 31.3% downward over the past 30 days.
View the complete Zacks Rank #5 Record.
Need the newest suggestions from Zacks Funding Analysis? Immediately, you possibly can obtain 7 Greatest Shares for the Subsequent 30 Days. Click on to get this free report
Neurocrine Biosciences, Inc. (NBIX): Free Inventory Evaluation Report
New Age Beverage Company (NBEV): Free Inventory Evaluation Report
Adherex Applied sciences Inc. (FENC): Free Inventory Evaluation Report
Stable Biosciences Inc. (SLDB): Free Inventory Evaluation Report
GreenTree Hospitality Group Ltd. Sponsored ADR (GHG): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.